Vaccine stocks slipped as RFK Jr.'s reshaped CDC panel, with half of its members skeptical of vaccines, begins reviewing COVID, flu, and RSV shot data. Retail sentiment turned bearish on Moderna, Pfizer, and Novavax. Traders fear policy shifts, with message volume spiking sharply ahead of the June 25-26 meet.